BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9186316)

  • 1. Protease inhibitors and urolithiasis.
    Sutherland SE; Reigle MD; Seftel AD; Resnick MI
    J Urol; 1997 Jul; 158(1):31-3. PubMed ID: 9186316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protease inhibitor-induced urolithiasis.
    Gentle DL; Stoller ML; Jarrett TW; Ward JF; Geib KS; Wood AF
    Urology; 1997 Oct; 50(4):508-11. PubMed ID: 9338723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Urinary lithiasis secondary to indinavir in an HIV-positive patient].
    Moyano Calvo JL; Huesa Martínez I; Cruz Navarro N; Leal Arenas J; León Dueñas E; Morales López A; Maestro Durán JL; Ramírez Mendoza A
    Arch Esp Urol; 2001 Dec; 54(10):1117-20. PubMed ID: 11852520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urolithiasis associated with the protease inhibitor indinavir.
    Bruce RG; Munch LC; Hoven AD; Jerauld RS; Greenburg R; Porter WH; Rutter PW
    Urology; 1997 Oct; 50(4):513-8. PubMed ID: 9338724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of urolithiasis in individuals seropositive for human immunodeficiency virus treated with indinavir is higher than previously assumed.
    Reiter WJ; Schön-Pernerstorfer H; Dorfinger K; Hofbauer J; Marberger M
    J Urol; 1999 Apr; 161(4):1082-4. PubMed ID: 10081842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of indinavir sulfate induced urolithiasis in HIV-positive patients.
    Kalaitzis C; Dimitriadis G; Tsatidis T; Kuntz R; Touloupidis S; Kelidis G
    Int Urol Nephrol; 2002; 34(1):13-5. PubMed ID: 12549631
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nephrolithiasis in a HIV infected patient treated with indinavir].
    Brzósko S; Hryszko T; Panasiuk B; Prokopowicz D; Myśliwiec M
    Przegl Lek; 2001; 58(6):528-9. PubMed ID: 11816748
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Urinary calculi and indinavir sulfate in patients with HIV infection. Apropos of 4 cases].
    Chefchaouni MC; Thiounn N; Flam T; Zerbib M; Debré B
    J Urol (Paris); 1997; 103(1-2):35-6. PubMed ID: 9765778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anuria in HIV+ patients treated with indinavir].
    Rebassa Llull MJ; Conte Visús A; Grases Freixedas F; Muñoz Vélez D; Mus Malleu A; Torrens Darder I; Sanz-Gadea CG; Ozonas Moragues M
    Arch Esp Urol; 2000 Oct; 53(8):719-21. PubMed ID: 11126974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of urinalysis abnormalities in HIV-positive individuals treated with indinavir.
    Gagnon RF; Tecimer SN; Watters AK; Tsoukas CM
    Am J Kidney Dis; 2000 Sep; 36(3):507-15. PubMed ID: 10977782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment of complicated renal colic in patients treated with indinavir: value of double J stents].
    Van Glabeke E; Conort P; Chartier-Kastler E; Desrez G; Boyer C; Richard F
    Prog Urol; 1999 Jun; 9(3):470-3. PubMed ID: 10434319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary stones in HIV-1-positive patients treated with indinavir.
    Daudon M; Estépa L; Viard JP; Joly D; Jungers P
    Lancet; 1997 May; 349(9061):1294-5. PubMed ID: 9142068
    [No Abstract]   [Full Text] [Related]  

  • 13. Indinavir urolithiasis: an emerging cause of renal colic in patients with human immunodeficiency virus.
    Kohan AD; Armenakas NA; Fracchia JA
    J Urol; 1999 Jun; 161(6):1765-8. PubMed ID: 10332431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urolithiasis and the protease inhibitor indinavir.
    Hermieu J; Prévot M; Ravery V; Sauty L; Moulinier F; Delmas V; Bouvet E; Boccon-Gibod L
    Eur Urol; 1999; 35(3):239-41. PubMed ID: 10072627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urolithiasis associated with protease inhibitors.
    Sundaram CP; Saltzman B
    J Endourol; 1999 May; 13(4):309-12. PubMed ID: 10405912
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe bleeding complications in HIV-positive haemophiliac patients treated with protease inhibitors.
    Hollmig KA; Beck SB; Doll DC
    Eur J Med Res; 2001 Mar; 6(3):112-4. PubMed ID: 11309224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased prevalence and analysis of risk factors for indinavir nephrolithiasis.
    Saltel E; Angel JB; Futter NG; Walsh WG; O'Rourke K; Mahoney JE
    J Urol; 2000 Dec; 164(6):1895-7. PubMed ID: 11061951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ["Buffalo neck": an unintended secondary effect of treatment with anti-HIV protease inhibitors].
    Milpied-Homsi B; Krempf M; Gueglio B; Raffi F; Stalder JF
    Ann Dermatol Venereol; 1999 Mar; 126(3):254-6. PubMed ID: 10394440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Indinavir and renal lithiasis].
    Traba Villameytide ML; Fernández-Guerrero M
    Actas Urol Esp; 2004; 28(7):523-6. PubMed ID: 15384277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urinary calculi and crystalluria in HIV+ patients treated with indinavir sulfate].
    Daudon M; Estépa L; Kébédé M; Viard JP; Montagnac R; Deray G; Bricaire F
    Presse Med; 1997 Nov; 26(34):1612-5. PubMed ID: 9452724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.